W4Y

1-{2-[(propan-2-yl)oxy]ethyl}-2-sulfanylidene-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one

Created:	2020-09-29
Last modified:	2020-12-16

Find Related PDB Entry
1 entries where W4Y is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	32
Chiral Atom Count	0
Bond Count	33
Aromatic Bond Count	5

2D diagram of W4Y

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-{2-[(propan-2-yl)oxy]ethyl}-2-sulfanylidene-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
Systematic Name (OpenEye OEToolkits)	1-(2-propan-2-yloxyethyl)-2-sulfanylidene-5~{H}-pyrrolo[3,2-d]pyrimidin-4-one
Formula	C₁₁ H₁₅ N₃ O₂ S
Molecular Weight	253.321
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1(=O)NC(N(CCOC(C)C)c2ccnc12)=S
SMILES	CACTVS	3.385	CC(C)OCCN1C(=S)NC(=O)c2[nH]ccc12
SMILES	OpenEye OEToolkits	2.0.7	CC(C)OCCN1c2cc[nH]c2C(=O)NC1=S
Canonical SMILES	CACTVS	3.385	CC(C)OCCN1C(=S)NC(=O)c2[nH]ccc12
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(C)OCCN1c2cc[nH]c2C(=O)NC1=S
InChI	InChI	1.03	InChI=1S/C11H15N3O2S/c1-7(2)16-6-5-14-8-3-4-12-9(8)10(15)13-11(14)17/h3-4,7,12H,5-6H2,1-2H3,(H,13,15,17)
InChIKey	InChI	1.03	FVJCUZCRPIMVLB-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB12440
Name	Verdiperstat
Groups	investigational
Description	Verdiperstat has been used in trials studying the basic science and treatment of Multiple System Atrophy (MSA).
Synonyms	Verdiperstat
Categories	Pyrimidines
CAS number	890655-80-8

Related Resource References

Resource Name	Reference
Pharos	CHEMBL4297594
PubChem	11528958
ChEMBL	CHEMBL4297594

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.